ReVance Therapeutics, Inc. (RVNC) Clinical Data To Be Presented In "Emerging Technologies" Panel At The International Symposium Of Facial Plastic Surgery In New York City
5/22/2014 9:03:59 AM
NEWARK, Calif., May 21, 2014 (GLOBE NEWSWIRE) -- Revance Therapeutics, Inc. (Nasdaq:RVNC), announced that the company's proprietary, botulinum toxin (BoNTA) investigational products will be the lead topics discussed in the Emerging Technologies panel at the 11th International Symposium of Facial Plastic Surgery in New York.
Help employers find you! Check out all the jobs and post your resume.
comments powered by